Rozprawy doktorskie na temat „Lung cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych rozpraw doktorskich naukowych na temat „Lung cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj rozprawy doktorskie z różnych dziedzin i twórz odpowiednie bibliografie.
Gaskin, Janet. "Radon and Lung Cancer". Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39003.
Pełny tekst źródłaThomas, Akesh, zainab Fatima i Girendra resident Hoskere. "Lung Cancer in Tennessee". Digital Commons @ East Tennessee State University, 2021. https://dc.etsu.edu/asrf/2021/presentations/69.
Pełny tekst źródłaRuiz, Rossana, Marco Galvez-Nino, Ebert Poquioma, Abel Limache-García, Edgar Amorin, Mivael Olivera, Natalia Valdiviezo i in. "Lung Cancer in Peru". Elsevier Inc, 2020. http://hdl.handle.net/10757/652438.
Pełny tekst źródłaRevisión por pares
Salvati, Valentina. "Development of effective lung cancer therapies based on lung cancer stem cella targeting". Doctoral thesis, Università di Catania, 2015. http://hdl.handle.net/10761/4035.
Pełny tekst źródłaŞeşen, Mustafa Berkan. "Lung cancer assistant : a hybrid clinical decision support application in lung cancer treatment selection". Thesis, University of Oxford, 2013. https://ora.ox.ac.uk/objects/uuid:e0dd01e4-3f18-49ed-89af-5e81894d4967.
Pełny tekst źródłaTurner, Nicola Jane. "Cancer in older people : studies in lung cancer". Thesis, University of Leeds, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.399662.
Pełny tekst źródłaOLSSON, MILLA, i CAROLINE ROSELL. "Telemedicine for Lung Cancer Patients". Thesis, KTH, Skolan för datavetenskap och kommunikation (CSC), 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-136951.
Pełny tekst źródłaNowadays the health care system in Sweden is faced with several challenges like shortage of space, physicians and long distances to specialized health care. A possible solution for this being discussed at the lung cancer department of Karolinska University 2 Hospital is the use of telemedicine. If implemented it would be part of the followup treatment. The objective of our research is to find out if this technology can help improve the health care. In order to investigate the opportunity for a telemedicine solution, we collected qualitative data from multiple different sources. This included two doctors specialized in lung cancer, and a focus group with nurses from Radiumhemmet. We also conducted interviews with relevant individuals outside the hospital including Nirav Desai who is the Founder and CEO of Hands On Telehealth; furthermore, we visited the Children’s Healthcare of Atlanta based in Atlanta, Georgia where telemedicine is used on a daily basis. Thanks to the carried out research, we have discovered that telemedicine could be used in certain scenarios and contribute towards a more frequent contact between the patient and the medical professionals. Thus, this new technique could help nurses execute lighter symptoms assessment remotely and reduce waiting times. We also discovered some inconveniences in a telemedicine solution designed for lung cancer patients. We personally do not think they are the best target group for such a solution since the patients are mostly the elderly with little computer experience. Also the disease is severe and requires physical examinations where the telemedicine existing today would not improve the care giving. To all intents and purposes, telemedicine might not be the only and ultimate solution for the problems identified within healthcare for lung cancer patients at Radiumhemmet, but it can work well as a supplement. 3
Basran, Parminder S. "Optimisation of lung cancer treatment". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/mq22568.pdf.
Pełny tekst źródłaTinnemans, Monique Maria Franciska Johanna. "Cytokinetic analysis of lung cancer". Maastricht : Maastricht : Universitaire Pers Maastricht ; University Library, Maastricht University [Host], 1996. http://arno.unimaas.nl/show.cgi?fid=7289.
Pełny tekst źródłaRichards, Elizabeth. "Molecular profiling of lung cancer". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24546.
Pełny tekst źródłaBingula, Rea. "Non-small cell lung cancer, immunity and microbiota : laying ground for the gut-lung-lung cancer axis in human subjects". Thesis, Université Clermont Auvergne (2017-2020), 2019. http://www.theses.fr/2019CLFAS009.
Pełny tekst źródłaLung cancer is the main cause of death by cancer worldwide. Despite the variety of available treatments, including surgery, chemotherapy, radiotherapy, and immune therapy, the average 5-year survival is 60%. One of the underlying reasons is a very high variability in patients’ susceptibility to treatment, explained by genetic background and since recently – our microbiota. The term microbiota includes bacteria, archaea, fungi, viruses and protists that inhabit our organism. The studies in animal models show that the gut microbiota (focused on bacteria) has a crucial role in host’s responsiveness to therapy through the stimulation of immune system. In this light, several “communication axes” between the gut and distal tumour sites have started to develop, including the “gut-lung” axis. However, the resident microbiota in the lungs that could directly influence the tumour response and interact with the gut microbiota has been scarcely characterised. To enable further development of the idea of the “gut-lung-lung cancer” axis, we included 18 non-small cell lung cancer (NSCLC) patients eligible for surgery and analysed the microbiota from four different lung samples (non-malignant, peritumoural and tumour tissue and bronchoalveolar lavage fluid; BAL), saliva and faeces by high-throughput sequencing. We also analysed several immune markers, as lymphocytic tumour infiltrate, Th and neutrophil profiles and cytokines in BAL and blood, and inflammatory markers in faeces along with short-chain fatty acids. Focusing first on the lungs, we show that BAL microbiota represents a significantly distinct community compared to lung tissue microbiota by providing detailed characterisation of the four different lung samples. Since tumours in lower lobes are reported as the ones with the worse prognosis, we investigated how the lobe location affected the microbiota composition. Peritumoural tissue and BAL microbiota were identified as the most affected in both abundance and diversity, and tumour as the least affected. However, phylum Firmicutes, previously reported as elevated in chronic obstructive pulmonary disease compared to controls, was found more abundant in microbiota from lower lung lobes. Therefore, we propose that both increase in Firmicutes and extensive changes in peritumoural tissue could be associated to increased aggressiveness of the lower lobe tumours. Next, we show that the presence of metastatic lymph nodes (LN), negative prognostic marker in NSCLC, significantly influence the local tissue microbiota in relation to its respiratory profile. We reported that anaerobic bacteria were more abundant within the tumour in the presence of metastatic LN, and aerobic bacteria within the one without it. Moreover, exactly inverse was observed for the same bacteria in extratumoural tissues. Along with migratory hypothesis depending on the bacterial preference for growth conditions shaped by tumour’s features, we propose several biomarkers for detection of metastatic LN that might facilitate their detection without imposing LN biopsy. Finally, we showed that BAL microbiota is the most associated to the local immune response and independent of the presence of metastatic LN. Future research will focus on the exploration of the interaction between the lung microbiota, systemic immunity and the gut microbiota
Grewal, Amardeep Singh. "Prevalence and Outcome of Lung Cancer in Lung Transplant Recipients". Thesis, Harvard University, 2015. http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295910.
Pełny tekst źródłaLi, Xinjun. "Familial risks for cancer with reference to lung cancer /". Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-007-9/.
Pełny tekst źródłaMoore, S. "The social construction of lung cancer : an analysis of representations of lung cancer in UK media". Thesis, University of Southampton, 2014. https://eprints.soton.ac.uk/372913/.
Pełny tekst źródłaHillinger, Sven. "Immune targeted therapy for lung cancer /". Zürich, 2006. http://opac.nebis.ch/cgi-bin/showAbstract.pl?sys=000253405.
Pełny tekst źródłaButtery, Robert Christians. "Integrin affinity modulation and lung cancer". Thesis, University of Edinburgh, 2006. http://hdl.handle.net/1842/29025.
Pełny tekst źródłaTran, Vanessa Hoang Medical Sciences Faculty of Medicine UNSW. "Breath biomarkers associated with lung cancer". Publisher:University of New South Wales. Medical Sciences, 2009. http://handle.unsw.edu.au/1959.4/43717.
Pełny tekst źródłaHochstenbag, Monique. "Imaging in clinical lung cancer staging". [Maastricht] : Maastricht : UPM, Universitaire Pers Maastricht ; University Library, Maastricht University [Host], 2003. http://arno.unimaas.nl/show.cgi?fid=8287.
Pełny tekst źródłaBuys, Timon Paul Hermus. "Clonal evoluation and lung cancer pharmacogenomics". Thesis, University of British Columbia, 2009. http://hdl.handle.net/2429/9532.
Pełny tekst źródłaWilkinson, Pauline. "Lung cancer in Ireland : 1991-1992". Thesis, Queen's University Belfast, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336721.
Pełny tekst źródłaDial, Christian W. "Adaptive Radiation Therapy for Lung Cancer". VCU Scholars Compass, 2014. http://scholarscompass.vcu.edu/etd/3579.
Pełny tekst źródłaRattican, Debra. "Symptom Clusters in Lung Cancer Patients". VCU Scholars Compass, 2012. http://scholarscompass.vcu.edu/etd/352.
Pełny tekst źródłaKurtyka, Courtney A. "Novel Therapeutic Strategies in Lung Cancer". Scholar Commons, 2014. https://scholarcommons.usf.edu/etd/5363.
Pełny tekst źródłaLee, Richard. "An improved system for lung cancer diagnosis using lung cell images". Diss., Online access via UMI:, 2006.
Znajdź pełny tekst źródłaTian, Fei. "Effect of the Hedgehog Pathway inhibitor GDC-0449 in lung cancer cells and lung cancer stem cells". Diss., Ludwig-Maximilians-Universität München, 2013. http://nbn-resolving.de/urn:nbn:de:bvb:19-156374.
Pełny tekst źródłaBrena, Romulo Martin. "Aberrant DNA methylation in human non-small cell lung cancer". Columbus, Ohio : Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1172083621.
Pełny tekst źródła陳潔盈 i Kit-ying Loucia Chan. "Expression analysis of Candidate cancer genes in non-small cell lung cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B45011163.
Pełny tekst źródłaCong, Chunling. "Statistical Analysis and Modeling of Breast Cancer and Lung Cancer". Scholar Commons, 2010. http://scholarcommons.usf.edu/etd/3563.
Pełny tekst źródłaSarvi, Sana. "Small cell lung cancer and cancer stem cell-like cells". Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/9542.
Pełny tekst źródłaDe, Souza Nicosha. "Molecular epidemiology of lung cancer in the Liverpool Lung Project (LLP) cohort". Thesis, University of Liverpool, 2014. http://livrepository.liverpool.ac.uk/2006199/.
Pełny tekst źródłaChan, Kit-ying Loucia. "Expression analysis of Candidate cancer genes in non-small cell lung cancer /". View the Table of Contents & Abstract, 2007. http://sunzi.lib.hku.hk/hkuto/record/B38480360.
Pełny tekst źródłaKeller, Elizabeth Greer. "Novel chemotherapeutics against lung and colon cancer". Click here for download, 2010. http://proquest.umi.com.ps2.villanova.edu/pqdweb?did=1961333981&sid=1&Fmt=2&clientId=3260&RQT=309&VName=PQD.
Pełny tekst źródłaMaltt, N. D. "Diagnosis of lung cancer by raman spectroscopy". Thesis, Queen's University Belfast, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492488.
Pełny tekst źródłaTomai, Evangelia. "Gap junctional communication in lung cancer cells". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape2/PQDD_0017/MQ54488.pdf.
Pełny tekst źródłaSmit, Egbert Frederik. "Aspects of palliative chemotherapy for lung cancer". [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 1990. http://irs.ub.rug.nl/ppn/292220588.
Pełny tekst źródłaOosterhout, Anselmus Gerardus Maria van. "Small cell lung cancer and brain metastasis". Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1995. http://arno.unimaas.nl/show.cgi?fid=6643.
Pełny tekst źródłaSeute, Tatjana. "Neurologic complications in small cell lung cancer". Maastricht : Maastricht : Universiteit Maastricht ; University Library, Universiteit Maastricht [host], 2008. http://arno.unimaas.nl/show.cgi?fid=9520.
Pełny tekst źródłaBelderbos, Josepha Sophia Antonia. "Radiotherapy in lung cancer: a moving field". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2007. http://dare.uva.nl/document/45315.
Pełny tekst źródłaWu, Mau-Ching. "Mouse models of human lung cancer development". Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.624711.
Pełny tekst źródłaLake, Sarah Louise. "Genetic analysis of LPHH1 in lung cancer". Thesis, University of Liverpool, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.404506.
Pełny tekst źródłaSalem, Ahmed. "Validating non-invasive therapeutic lung cancer biomarkers". Thesis, University of Manchester, 2018. https://www.research.manchester.ac.uk/portal/en/theses/validating-noninvasive-therapeutic-lung-cancer-biomarkers(edeb97f1-b1d4-43a3-bafb-8c7e1fa9d8c7).html.
Pełny tekst źródłaGray, Eoin. "Validating and updating lung cancer prediction models". Thesis, University of Sheffield, 2018. http://etheses.whiterose.ac.uk/19206/.
Pełny tekst źródłaTaylor, Fiona. "Biomarkers of lung cancer risk and progression". Thesis, University of Sheffield, 2019. http://etheses.whiterose.ac.uk/22855/.
Pełny tekst źródłaForrest, Lynne Fiona. "Intervention-generated inequalities in lung cancer care". Thesis, University of Newcastle upon Tyne, 2014. http://hdl.handle.net/10443/2396.
Pełny tekst źródłaMacaulay, Valentine. "Growth regulation in small cell lung cancer". Thesis, Imperial College London, 1989. http://hdl.handle.net/10044/1/47547.
Pełny tekst źródłaSinicropi-Yao, Sara Lu-Ming. "The Role of NOTCH1 in Lung Cancer". The Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu1522064811057979.
Pełny tekst źródłaMeikle, Claire K. "Platelet-Leukocyte Aggregation in Lung Cancer Patients". University of Toledo Health Science Campus / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=mco1555937904448281.
Pełny tekst źródłaRupniewska, Ewa. "Targeting SRC family kinases in lung cancer". Thesis, Imperial College London, 2012. http://hdl.handle.net/10044/1/9234.
Pełny tekst źródłaKvarnbrink, Samuel. "The importance og LRIG1 in lung cancer". Thesis, Umeå universitet, Onkologi, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-57834.
Pełny tekst źródłaWeber, Anika Maria. "Targeting ATM/ATR signalling in lung cancer". Thesis, University of Oxford, 2015. https://ora.ox.ac.uk/objects/uuid:3117219f-5273-4dc7-9a28-c531c708663f.
Pełny tekst źródła